From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration
- PMID: 37927596
- PMCID: PMC10622810
- DOI: 10.3389/fphar.2023.1269581
From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration
Abstract
Increased production and buildup of reactive oxygen species (ROS) can lead to various health issues, including metabolic problems, cancers, and neurological conditions. Our bodies counteract ROS with biological antioxidants such as SOD, CAT, and GPx, which help prevent cellular damage. However, if there is an imbalance between ROS and these antioxidants, it can result in oxidative stress. This can cause genetic and epigenetic changes at the molecular level. This review delves into how ROS plays a role in disorders caused by oxidative stress. We also look at animal models used for researching ROS pathways. This study offers insights into the mechanism, pathology, epigenetic changes, and animal models to assist in drug development and disease understanding.
Keywords: animal models; drug discovery; epigenetic marks; oxidative stress; reactive oxygen species.
Copyright © 2023 Afzal, Abdul Manap, Attiq, Albokhadaim, Kandeel and Alhojaily.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Albanes D., Heinonen O. P., Huttunen J. K., Taylor P. R., Virtamo J., Edwards B., et al. (1995). Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the alpha-tocopherol beta-carotene cancer prevention study. Am. J. Clin. Nutr. 62 (6), 1427S–1430S. 10.1093/ajcn/62.6.1427S - DOI - PubMed
-
- Albuquerque A. M., Tramujas L., Sewanan L. R., Williams D. R., Brophy J. M. (2022). Mortality rates among hospitalized patients with COVID-19 infection treated with tocilizumab and corticosteroids: a bayesian reanalysis of a previous meta-analysis. JAMA Netw. open 5 (2), e220548. 10.1001/jamanetworkopen.2022.0548 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
